Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

Subjects:

Time to stabilization in the mediolateral direction. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Participant’s data including characteristics and primary outcome measurement. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

Time to stabilization in the vertical direction. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

The description of games. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

Subjects:

The description of balance training. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

Mortality dataset used in analysis. by Samuel Sendagala (21417164)

Subjects:

Fig 11 - by Naveed Arshad (19712985)

Subjects:

Feed consumption of male Japanese quails exposed to various acetochlor concentrations. by Naveed Arshad (19712985)

Subjects:

Number of influenza tests performed between 2018 and 2022 by year. by Reem Eid (20889732)

Subjects:

Influenza Test Results and Dates of Testing (N = 973). by Reem Eid (20889732)

Subjects:

RSV test results in function of demographics. by Reem Eid (20889732)

Subjects:

Number of RSV tests performed between 2018 and 2022 by year. by Reem Eid (20889732)

Subjects:

Severity of different microscopic alterations in testes of quail exposed to different concentrations of acetochlor. by Naveed Arshad (19712985)

Subjects:

Fig 9 - by Naveed Arshad (19712985)

Subjects: